Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells

Clinical trial NCT04313322 · UNKNOWN

Trial details

NCT number: NCT04313322
Sponsor: Stem Cells Arabia
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Use of Stem Cells for COVID-19 Treatment

Start date: 2020-03-16
Primary completion: 2020-06-30
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.